Stocks and Investing Stocks and Investing
Tue, February 20, 2024

Corinne Johnson Initiated (avbp) at Strong Buy and Held Target at $27 on, Feb 20th, 2024


Published on 2024-10-28 09:04:50 - WOPRAI, Corinne Johnson
  Print publication without navigation


Corinne Johnson of Goldman Sachs, Initiated "ArriVent BioPharma, Inc." (AVBP) at Strong Buy and Held Target at $27 on, Feb 20th, 2024.

Corinne, nor any peers, have made any analyst calls on AVBP in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources